Under translational dietary conditions (i.e., using a HFD with a macronutrient composition and cholesterol content comparable to human diets) [17], these mice develop NASH with fibrosis in the context of obesity, insulin resistance, adipose tissue inflammation, and gut dysfunction, as is typical for many NASH patients [18]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatohepatitis.